AI IntelligenceApr 24, 2026Secondary Market
Article
IBRX
ImmunityBio, Inc. (IBRX) is the subject of a securities fraud class action lawsuit. The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the lawsuit against the Company. The details were filed in an SEC 8-K.
Data Cube AI EditorialSource: PR Newswire
01
Source Brief
ImmunityBio, Inc. (IBRX) is the subject of a securities fraud class action lawsuit. The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the lawsuit against the Company. The details were filed in an SEC 8-K.
02